Website, packaging and an investor deck for a clinical-grade anti-inflammaging supplement

Subject

INFLOMEGA is a clinical-grade supplement built on a patented synbiotic technology that converts Omega-3 into resolvins — the molecules the body uses to actively resolve inflammation rather than just suppress it. The same product is sold through the VOLMI store, but INFLOMEGA needed its own identity and a set of materials well beyond a product page: a website, packaging, a box insert, and an investor-facing pitch deck. The client supplied the science — peer-reviewed studies, market sizing, clinical claims — and we designed how all of it looked and read.

What have we done

Task

The client had the hard part done — a patented technology, peer-reviewed studies, a defined market and a business model — but none of it had a visual language yet. Explaining "inflammaging" and resolvins to three different audiences at once (consumers, doctors, investors) in one month, with a two-person team, meant every format had to share one system instead of being designed from scratch each time.

Solution

We built one dark, lab-grade visual language — the same typography, colour logic and biotech imagery — and reused it across every format instead of restyling for each audience. The website leads with the "inflammaging" concept before the product itself, because the science is the differentiator, not the bottle. The same system scales down into the packaging and insert for someone who already bought it, and scales up into the pitch deck for whoever is deciding whether to fund or stock it.

The same visual system carries into the packaging and the box insert — dosage, ingredient sourcing and the "why this works" explanation someone reads while already holding the bottle, not while browsing a website.